- Home
- PNST vs LPCN Comparison
PNST vs LPCN Comparison
Compare PNST & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNST
- LPCN
- Stock Information
- Founded
- PNST 2007
- LPCN 1997
- Country
- PNST United States
- LPCN United States
- Employees
- PNST N/A
- LPCN N/A
- Industry
- PNST Blank Checks
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- PNST Finance
- LPCN Health Care
- Exchange
- PNST Nasdaq
- LPCN Nasdaq
- Market Cap
- PNST 18.1M
- LPCN 19.4M
- IPO Year
- PNST N/A
- LPCN N/A
- Fundamental
- Price
- PNST $0.32
- LPCN $3.38
- Analyst Decision
- PNST Strong Buy
- LPCN Strong Buy
- Analyst Count
- PNST 3
- LPCN 1
- Target Price
- PNST $2.50
- LPCN $10.00
- AVG Volume (30 Days)
- PNST 87.0K
- LPCN 33.0K
- Earning Date
- PNST 02-19-2025
- LPCN 03-06-2025
- Dividend Yield
- PNST N/A
- LPCN N/A
- EPS Growth
- PNST N/A
- LPCN N/A
- EPS
- PNST N/A
- LPCN N/A
- Revenue
- PNST $123,579,000.00
- LPCN $7,922,926.00
- Revenue This Year
- PNST $15.43
- LPCN N/A
- Revenue Next Year
- PNST $17.79
- LPCN N/A
- P/E Ratio
- PNST N/A
- LPCN N/A
- Revenue Growth
- PNST 11.06
- LPCN N/A
- 52 Week Low
- PNST $0.31
- LPCN $3.20
- 52 Week High
- PNST $4.26
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- PNST 39.45
- LPCN 30.99
- Support Level
- PNST $0.31
- LPCN $3.42
- Resistance Level
- PNST $0.50
- LPCN $3.62
- Average True Range (ATR)
- PNST 0.06
- LPCN 0.26
- MACD
- PNST -0.00
- LPCN -0.02
- Stochastic Oscillator
- PNST 5.56
- LPCN 1.61
About PNST Pinstripes Holdings Inc.
Pinstripes Holdings Inc is an experiential dining and entertainment concept combining exceptional Italian-American cuisine with bowling, bocce, and private events. It owns and operates around 17 restaurants in the USA. The company designs and constructs large-format locations that are each 26,000 to 38,000 square feet of interior space, plus additional outdoor patio space that includes outdoor dining, bocce courts, fire-pits, and decorative fountains.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.